Two Models of Legalization of Psychedelic Substances: Reasons for Concern.
William R. Smith, Paul S. Appelbaum
JAMA August 1, 2021 DOI: 10.1001/jama.2021.12481 via PubMed Central
Summary
AI-generated from the abstractPsychedelic substance legalization initiatives raise concerns that can be informed by cautionary precedents from the legalization and commercialization of other controlled substances.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Citations | 60 |
| Key finding | Legalization initiatives for psychedelic substances raise concerns that are illuminated by cautionary precedents involving other controlled substances. |
Abstract
This Viewpoint reviews legalization initiatives for psychedelic substances and the concerns they raise by looking to the cautionary precedents involving the legalization and commercialization of other controlled substances.